Press release
Bispecific Antibody Therapeutics Contract Manufacturing Market Latest Survey Report 2024
InsightAce Analytic Pvt. Ltd. announces the release of the market assessment report on "Global Bispecific Antibody Therapeutics Contract Manufacturing Market Size, Share & Trends Analysis Report By Indication (Cancer, Infectious Diseases, Autoinflammatory and autoimmune diseases, CNS Conditions, and Others), By Route of Administration (Intravenous, Subcutaneous, and Others), By End-users (Pharmaceutical Companies, Biopharmaceutical Companies, and Others) Market Outlook And Industry Analysis 2031"
According to the latest research by InsightAce Analytic, the global Bispecific Antibody Therapeutics Contract Manufacturing Market size is valued at US$ 5.39 Bn in 2022, and it is expected to reach US$ 82.85 Bn in 2031, recording a promising CAGR of 35.6% during the forecast period of 2023-2031.
Bispecific Antibody Therapeutics Contract Manufacturing Market Report Scope
Report Attribute Specifications
Market Size Value In 2022 USD 5.39 Bn
Revenue Forecast In 2031 USD 82.85 Bn
Growth Rate CAGR CAGR of 35.6 % from 2023 to 2031
Quantitative Units Representation of revenue in US$ Bn and CAGR from 2023 to 2031
Historic Year 2019 to 2022
Forecast Year 2023-2031
Report Coverage The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends
Segments Covered By Indication, By Route of Administration, By End-users
Regional Scope North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country Scope U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia
Competitive Landscape Lonza, Roche's, Creative Biolabs, AbbVie, Amgen, Janssen, Johnson & Johnson, IQVIA, WuXi Biologics, Sino Biological Inc., and Others.
Request for Free Sample Pages: https://www.insightaceanalytic.com/request-sample/1996
Bispecific antibody drugs have unique biological and pharmacological characteristics and are available in various formats, making them beneficial for therapeutic use. The surging pipeline of bispecific antibodies and the rising number of related clinical trials show high interest and investment in this field.
Contract manufacturing services (CMS) play a significant role in rapidly introducing new and improved business products. CMS offers the necessary developmental resources and expertise to support the production of novel therapies.
The interest in bispecific antibody therapies is increasing, as evidenced by the approval of seven drug candidates last year. Expect more such approvals in the upcoming years, as many drug candidates are currently in Phase-III clinical trials and are showing promising results. For instance, Sino Biological Inc. said more than 85% of bispecific antibodies in clinical trials are cancer therapeutics.
Some of the prominent players in the Bispecific Antibody Therapeutics Contract Manufacturing Market are:
• Lonza
• Roche's
• Creative Biolabs
• AbbVie
• Amgen
• Janssen
• Johnson & Johnson
• IQVIA
• WuXi Biologics
• Sino Biological Inc.
• Other Prominent Players
Market Dynamics:
Drivers:
The fundamental market players in this market are making efforts to expand their businesses through strategic activities such as collaborations, acquisitions and partnerships, which has boomed the market's growth. In addition, rising cases of cancer & other chronic diseases, increasing research and development (R&D) activities, rising number of clinical trials, growing pipeline of anti-cancer therapeutics, and high demand for novel therapeutic methods support the growth of the Bispecific Antibody Therapeutics Contract Manufacturing Market.
Challenges:
However, the complex and time-consuming manufacturing processes, high-quality standards, and supply chain management are challenging factors in this market.
Regional Trends:
The North America Bispecific Antibody Therapeutics Contract Manufacturing Market is expected to register the highest market revenue share over the forecast period 2023-2031. The market's expansion in this region is mainly driven by increased demand for advanced therapeutic treatments, a growing number of market players, advancements in medical technologies, a rising burden of cancer, increasing government efforts to improve clinical treatments, and improved developmental capabilities of contract manufacturing companies.
Curious about this latest version of the report? @ https://www.insightaceanalytic.com/enquiry-before-buying/1996
Key developments in the market:
• In August 2022, The European Commission granted Johnson & Johnson company's TECVAYLI (teclistamab) with conditional marketing authorization. TECVAYLI (teclistamab) is a monotherapy for treating adult patients with relapsed & refractory multiple myeloma.
• In June 2022, Roche received a grant from the European Commission for CD20xCD3 T-cell binding bsAB Lunsumio (mosunetuzumab. It is helpful for treating follicular lymphoma, relapsed or refractory, in patients who have received two prior systemic therapies.
• In March 2022, Sino Biological, Inc. announced a CRO services partnership with Ainnocence, Inc.. Under the terms of this partnership, Sino Biological added Ainnocence's cutting-edge artificial intelligence-based prediction technology to its current antibody development CRO services offering.
Market Segments
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Indication
• Cancer
• Infectious Diseases;
• Autoinflammatory and autoimmune diseases
• CNS Conditions
• Others
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Route of Administration
• Intravenous
• Subcutaneous
• Others
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on End-users
• Pharmaceutical Companies
• Biopharmaceutical Companies
• Others
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2023 to 2031 based on Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
North America Bispecific Antibody Therapeutics Contract Manufacturing Market Revenue (US$ Bn) by Country, 2023 to 2031
• U.S.
• Canada
Europe Bispecific Antibody Therapeutics Contract Manufacturing Market Revenue (US$ Bn) by Country, 2023 to 2031
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe
Asia Pacific Bispecific Antibody Therapeutics Contract Manufacturing Market Revenue (US$ Bn) by Country, 2023 to 2031
• India
• China
• Japan
• South Korea
• Australia & New Zealand
Latin America Bispecific Antibody Therapeutics Contract Manufacturing Market Revenue (US$ Bn) by Country, 2023 to 2031
• Brazil
• Mexico
• Rest of Latin America
Middle East & Africa Bispecific Antibody Therapeutics Contract Manufacturing Market Revenue (US$ Bn) by Country, 2023 to 2031
• GCC Countries
• South Africa
• Rest of Middle East & Africa
Obtain Report Customization Details @ https://www.insightaceanalytic.com/customisation/1996
Why should buy this report:
To receive a comprehensive analysis of the prospects for the global Bispecific Antibody Therapeutics Contract Manufacturing Market
To receive an industry overview and future trends in the global Bispecific Antibody Therapeutics Contract Manufacturing Market
To analyze the Bispecific Antibody Therapeutics Contract Manufacturing Market drivers and challenges
To get information on the Bispecific Antibody Therapeutics Contract Manufacturing Market size value (US$ Mn) forecast till 2031
Major Investments, Mergers & Acquisitions in the global Bispecific Antibody Therapeutics Contract Manufacturing Market industry
Other Related Reports Published by InsightAce Analytic:
CD Targeted Bispecific Antibody Market
Antibody Purification Services Market
Live Biotherapeutic Products And Microbiome Contract Manufacturing Market
Contact Us:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 551 226 6109
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to v vv expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis of key market insights in a timely and cost-effective manner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Bispecific Antibody Therapeutics Contract Manufacturing Market Latest Survey Report 2024 here
News-ID: 3346539 • Views: …
More Releases from InsightAce Analytic Pvt.Ltd
AI In The Credit-Scoring Market Smarter Credit Decisions: How AI is Transforming …
AI In The Credit-Scoring Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global AI In The Credit-Scoring Market - (By Component (Software and Service), By Application (Personal Credit Scoring and Corporate Credit Scoring), By Industry Vertical (BFSI (Banking, Financial Services, Insurance), Retail, Healthcare,
Telecommunications, Utilities, and Real Estate)), Trends,…
Surgical Robotics Simulation Market Guiding the Next Generation of Surgeons: Gro …
Surgical Robotics Simulation Market Worth $1,283.6 Mn by 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Surgical Robotics Simulation Market Size, Share & Trends Analysis Report By Product Type (Product, Services), By Application (General Surgery, Gynecological Surgery, Urological Surgery, Neurological Surgery (Head and Neck Surgery), Cardiological Surgery, Orthopedic Surgery, Others), By End User (Hospitals, Ambulatory Surgical Centers,…
AI Studio Market Accelerating Innovation: The Benefits of AI Studios for Busines …
Global AI Studio Market Worth $57.89 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd.
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global AI Studio Market- (By Application (Sentiment Analysis, Customer Service Automation, Image Classification & Labelling, Synthetic Data Generation, Predictive Modelling & Forecasting, Automatic Content Generation, and Others), By Offering, By Vertical, By Region, Trends, Industry Competition Analysis, Revenue and Forecast…
Human-Induced Pluripotent Stem Cells (hiPSCs) Preclinical Disease Model Market G …
Global Human-Induced Pluripotent Stem Cells (hiPSCs) Preclinical Disease Model Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Human-Induced Pluripotent Stem Cells (hiPSCs) Preclinical Disease Model Market- (Disease (Neurological Disorders and Dystrophies, Cardiac disorders, Retinal Eye Disease, Metabolic Disorders, Liver disease, Others), Products and Services (Disease Model,
Reprogramming service, Differentiation…
More Releases for Bispecific
Global Bispecific Antibody Market Size Bispecific Antibodies Clinical Trials FDA …
Global Bispecific Antibody Market, Drugs Sales, Patent, Price and Clinical Trials Insight 2029 Report Highlights:
• Bispecific Antibodies Development Proprietary Platforms Insight: > 30 Platforms
• Global Bispecific Antibodies Market Size Yearly and Quarterly Sales (2018 till 2023)
• Global Bispecific Antibodies Market Size 2023: > USD 8 Billion
• Global Bispecific Antibodies Market Forecast Till 2029
• Approved Bispecific Antibodies Yearly and Quarterly Sales (2018 till 2023)
• Approved Bispecific Antibodies Regional Sales (2018 till 2023)
• Clinical and Commercial Insight On Approved…
Bispecific Drug Innovation - Creative Biolabs Concludes Its Journey at the 15th …
On September 5, Creative Biolabs successfully concluded its participation in the 15th Annual World Bispecific Summit.
New York, USA - September 10, 2024 - The summit brought together leading experts in the bispecific antibody [https://www.creative-biolabs.com/bsab/bispecific-antibody-bsab-development-service.htm] (BsAb) field from around the globe, offering attendees a rich platform to discuss cutting-edge developments and future directions.
Image: https://www.getnews.info/uploads/b7ea13d648fcb7917ba9b55571b2ba35.png
In recent years, this field has grown rapidly, becoming a focal point in biopharmaceutical research and development. A…
Bispecific Antibody Drug Conjugates Development
The development of bispecific antibody drug conjugates (ADCs) marks a significant advancement in the field of targeted cancer therapy. These innovative molecules combine the specificity of bispecific antibodies with the powerful cytotoxic effects of drug conjugates, creating a new class of therapeutic agents that hold great promise for treating complex and resistant cancers. The process of developing these ADCs involves intricate design, engineering, and testing to ensure their safety, efficacy,…
Bispecific Antibodies: Revolutionizing Targeted Cancer Therapy
Bispecific antibodies (BsAbs) are revolutionizing targeted cancer therapy by offering a dual-targeting approach that enhances therapeutic efficacy and addresses tumor heterogeneity. These engineered antibodies are designed to recognize and bind two different antigens simultaneously, providing a more comprehensive attack on cancer cells and improving treatment outcomes.
One of the most successful examples of BsAbs is blinatumomab, which targets CD19 on B-cells and CD3 on T-cells. Blinatumomab has shown remarkable efficacy in…
Global Bispecific Antibody Market Research Report Forecast 2017 to 2021Global Bi …
Report Hive Market Research Released a New Research Report of 119 pages on Title " Global Bispecific Antibody Market Research Report Forecast 2017 to 2021 "with detailed Analysis, Forecast and Strategies.
The Global Bispecific Antibody Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the Bispecific Antibody industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as…
Bispecific Antibodies Market - Global Industry Analysis 2024
Bispecific Antibodies Market Overview
Bispecific antibody (BsAb) is an artificial protein that is composed of fragments of two different monoclonal antibodies and has ability to bind to two different types of antigen. Cancer immunotherapy is the most widely explored application of bispecific antibody. Lung, breast and colon cancer are the wider applications of BsAb. Bispecific antibody simultaneously binds to a cytotoxic cell and target tumor cell and destroys it. Bispecific antibodies…
